KBR reported first quarter fiscal 2026 revenues of $1.9 billion, down 5% due to expected EUCOM contingency runoff, with net income attributable to KBR falling 12% to $102 million. Operating income decreased 11% to $180 million, while adjusted EBITDA rose slightly by 1% to $251 million. The company reaffirmed its full-year fiscal 2026 guidance and is progressing with a planned spin-off of its Mission Technology Solutions segment to create two focused public companies, aiming to enhance strategic focus and shareholder value. Backlog remains strong at $23.2 billion with a book-to-bill ratio of 1.1x, indicating steady demand across core markets.
Silvaco and NVIDIA have teamed up to enhance semiconductor design and manufacturing by integrating NVIDIA's AI and accelerated computing with Silvaco's physics-based simulation technology. This collaboration aims to create high-fidelity digital twins...
Dr. Dajun Yang, Chairman and CEO of Ascentage Pharma, was ranked No. 3 on The Medicine Maker Power List 2026 in the Small Molecules category, recognizing his leadership in oncology drug development. Under his guidance, Ascentage Pharma has advanced i...
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) remains a hold for investors seeking defensive exposure to companies with long-term dividend growth. It provides a 2% starting yield and an 8.57% three-year dividend growth rate, ensuring income s...
Chipotle Mexican Grill launched its first restaurant in Mexico on July 16 in San Pedro Garza García, Nuevo León, partnering with Alsea. This marks the beginning of Chipotle's international growth strategy in Mexico, with plans to open more locations ...
AI investment is rapidly increasing, with hyperscaler spending expected to grow from $673 billion in 2024 to $892 billion by 2028. Despite strong revenue growth from companies like Alphabet, concerns about overinvestment have caused significant marke...
